Medical device recalls Moderate risk

BioMerieux SA recalls ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging ETEST is a quantitative technique for determining the an…

Recall date
April 25, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-2095-2017
FDA classification
Class II
Brand / firm
BioMerieux SA
Sold / distributed
NATIONWIDE DISTRIBUTION TO AL, AZ, AR, CA, CO, CT, DE, DC, FL, GA, HI, IL, IN, IA, KS, KY, LA, M, MA, MD, MI, MN, MS, MO, MT, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, and WY

Why it was recalled

False susceptible results

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria (Only 531640 was distributed in the United States)

Get recall alerts

Free email alert whenever BioMerieux SA has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: BioMerieux SA